David Q. Pham, PharmD, BCPS, CDE
Associate Professor of Pharmacy Practice and Administration
College of Pharmacy
E-Mail: dqpham@westernu.edu
Phone: 909-706-3522 | Join year: August, 2002
Education
PharmD 2001
University of the Pacific
Education Experience
Residency
Pharmacy Practice 2001-2002
St. Joseph's Medical Center
Certification
Board Certified Pharmacotherapy Specialist (BCPS)
2005 Board of Pharmaceutical Specialties
Certified Diabetes Educator (CDE)
2012 National Certification Board for Diabetes Educators
Professional Experience
His interests include teaching, scholarship, and service to both the College of Pharmacy as well as the community.
Work Site
Mary & Dick Allen Diabetes Center
Hoag Hospital
520 Superior Ave., Suite 150
Newport Beach, CA 92663
American Diabetes Association
Western Division, Orange County
151 Kalmus Dr. #C-100
Costa Mesa, CA 92626
This ambulatory care rotation allows third and fourth year Pharm.D. candidates to assist in the care and education of patients with diabetes mellitus at the Mary & Dick Allen Diabetes Center at Hoag Hospital three days per week. Student pharmacists will also spend two days weekly raising public awareness of diabetes at the American Diabetes Association.
Teaching Experience
He has been a member of the pharmacy faculty since August 2002.
Organizations
Dr. Pham is very active in pharmacy organizations both at the local and state level.
Publication
Pham DQ, Nogid A, Plakogiannis R. Sitagliptin: a novel agent for the management of type 2 diabetes mellitus. American Journal of Health-System Pharmacy 2008;65:521-31.
Pham DQ, Cohen H, Chu V. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Journal of Clinical Pharmacology 2007;47:890-903.
Pham AQ, Kourlas H, Pham DQ. Cinnamon supplementation in type 2 diabetes mellitus. Pharmacotherapy 2007;27:595-9.
Nogid A, Pham DQ. Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus. Pharmacotherapy 2006;26:1626-40.
Pham DQ, Plakogiannis R. Vitamin E supplementation in cardiovascular disease and cancer prevention: Part 1. Annals of Pharmacotherapy 2005;39:1870-8.